"Study data regarding the Crux VCF suggests that it is very successful in addressing the problem of filter tilt commonly associated with other commercially available IVC filter technologies.

Optional vena cava filters can used to provide either ... Reproduced with permission from Rafael Medical Technologies, Inc. C, Crux Filter (Crux Biomedical, Portola Valley, CA).

MENLO PARK, Calif., Oct. 21 Crux Biomedical Inc. announced today that it was awarded a U.S. patent, (US 7,582,100 B2), for its novel vena cava filter. The filter, which is designed to trap blood ...

San Francisco, CA - The Food and Drug Administration (FDA) has approved a new vena cava filter made by Crux Biomedical (Menlo Park, CA), said to be the first such device to facilitate ...

The company has developed an advanced implantable vena cava filter designed to address the complications seen with current VCFs. "The Crux device represents the first significant design innovation ...

clearance for its Crux VCF System, an innovative IVC filter designed to facilitate bi-directional retrieval through either the femoral or jugular veins. Under terms of the agreement, Volcano will ...